Please login to the form below

Not currently logged in
Email:
Password:

Senior changes at Merck KGaA

New head of controlling for its healthcare business

Merck KGaA, Andreas Stickler Germany's Merck KGaA has announced changes to its senior financial team for its healthcare operations.

Andreas Stickler (pictured top right) has been appointed as new head of controlling of the healthcare business sector where he will be responsible for the operations of Merck's pharma division Merck Serono, its consumer health business, biosmilars and allergy subsidiary Allergopharma.

Stickler is a 12-year veteran of Merck and has been head of mergers and acquisitions since 2008, leading the takeover of Millipore in 2010. He previously worked at Degussa, Aventis and Hoechst.

Merck 
KGaA, Roman WerthAnother Merck employee Roman Morten Werth (pictured bottom right) will assume Stickler's former position as head of mergers and acquisitions, a department he has been part of since joining Merck in 2008. He was previously manager of mergers and acquisitions for technology firm Siemens.

Merck's chief financial officer Marcus Kuhnert said: “We're delighted that two key positions in our finance function will be filled with internal managers who bring the experience and the track record to ensure quality and continuity alike.”

 

2nd February 2015

From: PME

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite Digital

We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...